By transferring MLL/AF9-OVA leukemia-initiating cells into non-irradiated immunocompetent mice, we investigated whether the spontaneous antigen-specific CTL response could suppress development of leukemia, and also how leukemia develops despite the presence of a CTL response to an immunogenic leukemia antigen. This evidence concerns the gene KMT2A and leukemia.